<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35373853</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-1136</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>70</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Glia</Title>
          <ISOAbbreviation>Glia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Survival motor neuron protein deficiency alters microglia reactivity.</ArticleTitle>
        <Pagination>
          <StartPage>1337</StartPage>
          <EndPage>1358</EndPage>
          <MedlinePgn>1337-1358</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.24177</ELocationID>
        <Abstract>
          <AbstractText>Survival motor neuron (SMN) protein deficiency results in loss of alpha motor neurons and subsequent muscle atrophy in patients with spinal muscular atrophy (SMA). Reactive microglia have been reported in SMA mice and depleting microglia rescues the number of proprioceptive synapses, suggesting a role in SMA pathology. Here, we explore the contribution of lymphocytes on microglia reactivity in SMA mice and investigate how SMN deficiency alters the reactive profile of human induced pluripotent stem cell (iPSC)-derived microglia. We show that microglia adopt a reactive morphology in spinal cords of SMA mice. Ablating lymphocytes did not alter the reactive morphology of SMA microglia and did not improve the survival or motor function of SMA mice, indicating limited impact of peripheral immune cells on the SMA phenotype. We found iPSC-derived SMA microglia adopted an amoeboid morphology and displayed a reactive transcriptome profile, increased cell migration, and enhanced phagocytic activity. Importantly, cell morphology and electrophysiological properties of motor neurons were altered when they were incubated with conditioned media from SMA microglia. Together, these data reveal that SMN-deficient microglia adopt a reactive profile and exhibit an exaggerated inflammatory response with potential impact on SMA neuropathology.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. GLIA published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Khayrullina</LastName>
            <ForeName>Guzal</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alipio-Gloria</LastName>
            <ForeName>Zaida A</ForeName>
            <Initials>ZA</Initials>
            <AffiliationInfo>
              <Affiliation>Calibr, Scripps Research Institute, La Jolla, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deguise</LastName>
            <ForeName>Marc-Olivier</ForeName>
            <Initials>MO</Initials>
            <Identifier Source="ORCID">0000-0002-3802-1195</Identifier>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gagnon</LastName>
            <ForeName>Sabrina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chehade</LastName>
            <ForeName>Lucia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stinson</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belous</LastName>
            <ForeName>Natalya</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bergman</LastName>
            <ForeName>Elizabeth M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lischka</LastName>
            <ForeName>Fritz W</ForeName>
            <Initials>FW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rotty</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dalgard</LastName>
            <ForeName>Clifton L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kothary</LastName>
            <ForeName>Rashmi</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-9239-7310</Identifier>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnson</LastName>
            <ForeName>Kristen A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Calibr, Scripps Research Institute, La Jolla, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burnett</LastName>
            <ForeName>Barrington G</ForeName>
            <Initials>BG</Initials>
            <Identifier Source="ORCID">0000-0002-5001-3358</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>PJT-156379</GrantID>
            <Acronym>CAPMC</Acronym>
            <Agency> CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>R01NS091575</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 GM134104</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>RO1GM134104</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS094721</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS091575</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS119594</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01NS094721</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Glia</MedlineTA>
        <NlmUniqueID>8806785</NlmUniqueID>
        <ISSNLinking>0894-1491</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D055533">Survival of Motor Neuron 1 Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011488" MajorTopicYN="Y">Protein Deficiency</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055533" MajorTopicYN="N">Survival of Motor Neuron 1 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">induced pluripotent stem cell</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">microglia</Keyword>
        <Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword>
        <Keyword MajorTopicYN="N">survival motor neuron</Keyword>
      </KeywordList>
      <CoiStatement>Competing Interests. Neither I nor my family members have a financial interest in any commercial product, service, or organization providing financial support for this research.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>8</Hour>
          <Minute>43</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35373853</ArticleId>
        <ArticleId IdType="mid">NIHMS1793183</ArticleId>
        <ArticleId IdType="pmc">PMC9081169</ArticleId>
        <ArticleId IdType="doi">10.1002/glia.24177</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Akten B, Kye MJ, Hao le T, Wertz MH, Singh S, Nie D, … Sahin M (2011). Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc Natl Acad Sci U S A, 108(25), 10337–10342. doi:10.1073/pnas.1104928108</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1104928108</ArticleId>
            <ArticleId IdType="pmc">PMC3121858</ArticleId>
            <ArticleId IdType="pubmed">21652774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alliot F, Godin I, &amp; Pessac B (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res, 117(2), 145–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10567732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ando S, Osanai D, Takahashi K, Nakamura S, Shimazawa M, &amp; Hara H (2020). Survival motor neuron protein regulates oxidative stress and inflammatory response in microglia of the spinal cord in spinal muscular atrophy. J Pharmacol Sci, 144(4), 204–211. doi:10.1016/j.jphs.2020.09.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jphs.2020.09.001</ArticleId>
            <ArticleId IdType="pubmed">33070839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arumugam S, Garcera A, Soler RM, &amp; Tabares L (2017). Smn-Deficiency Increases the Intrinsic Excitability of Motoneurons. Front Cell Neurosci, 11, 269. doi:10.3389/fncel.2017.00269</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2017.00269</ArticleId>
            <ArticleId IdType="pmc">PMC5591959</ArticleId>
            <ArticleId IdType="pubmed">28928636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanquie O, &amp; Bradke F (2018). Cytoskeleton dynamics in axon regeneration. Curr Opin Neurobiol, 51, 60–69. doi:10.1016/j.conb.2018.02.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.conb.2018.02.024</ArticleId>
            <ArticleId IdType="pubmed">29544200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowerman M, Murray LM, Beauvais A, Pinheiro B, &amp; Kothary R (2012). A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul Disord, 22(3), 263–276. doi:10.1016/j.nmd.2011.09.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2011.09.007</ArticleId>
            <ArticleId IdType="pubmed">22071333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowerman M, Shafey D, &amp; Kothary R (2007). Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J Mol Neurosci, 32(2), 120–131. doi:10.1007/s12031-007-0024-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-007-0024-5</ArticleId>
            <ArticleId IdType="pubmed">17873296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyer JG, Deguise MO, Murray LM, Yazdani A, De Repentigny Y, Boudreau-Lariviere C, &amp; Kothary R (2014). Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. Hum Mol Genet, 23(16), 4249–4259. doi:10.1093/hmg/ddu142</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu142</ArticleId>
            <ArticleId IdType="pmc">PMC4103674</ArticleId>
            <ArticleId IdType="pubmed">24691550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bricceno KV, Martinez T, Leikina E, Duguez S, Partridge TA, Chernomordik LV, … Burnett BG (2014). Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Hum Mol Genet, 23(18), 4745–4757. doi:10.1093/hmg/ddu189</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu189</ArticleId>
            <ArticleId IdType="pmc">PMC4140458</ArticleId>
            <ArticleId IdType="pubmed">24760765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, … Hunot S (2009). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest, 119(1), 182–192. doi:10.1172/JCI36470</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI36470</ArticleId>
            <ArticleId IdType="pmc">PMC2613467</ArticleId>
            <ArticleId IdType="pubmed">19104149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burghes AH, &amp; Beattie CE (2009). Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Nat Rev Neurosci, 10(8), 597–609. doi:10.1038/nrn2670</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn2670</ArticleId>
            <ArticleId IdType="pmc">PMC2853768</ArticleId>
            <ArticleId IdType="pubmed">19584893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervero C, Blasco A, Tarabal O, Casanovas A, Piedrafita L, Navarro X, … Caldero J (2018). Glial Activation and Central Synapse Loss, but Not Motoneuron Degeneration, Are Prevented by the Sigma-1 Receptor Agonist PRE-084 in the Smn2B/− Mouse Model of Spinal Muscular Atrophy. J Neuropathol Exp Neurol, 77(7), 577–597. doi:10.1093/jnen/nly033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jnen/nly033</ArticleId>
            <ArticleId IdType="pubmed">29767748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaplin DD (2010). Overview of the immune response. J Allergy Clin Immunol, 125(2 Suppl 2), S3–23. doi:10.1016/j.jaci.2009.12.980</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2009.12.980</ArticleId>
            <ArticleId IdType="pmc">PMC2923430</ArticleId>
            <ArticleId IdType="pubmed">20176265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaytow H, Huang YT, Gillingwater TH, &amp; Faller KME (2018). The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci, 75(21), 3877–3894. doi:10.1007/s00018-018-2849-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-018-2849-1</ArticleId>
            <ArticleId IdType="pmc">PMC6182345</ArticleId>
            <ArticleId IdType="pubmed">29872871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, … Luster AD (2010). Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity, 33(2), 266–278. doi:10.1016/j.immuni.2010.07.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2010.07.018</ArticleId>
            <ArticleId IdType="pmc">PMC3155777</ArticleId>
            <ArticleId IdType="pubmed">20727790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crehan H, Hardy J, &amp; Pocock J (2012). Microglia, Alzheimer’s disease, and complement. Int J Alzheimers Dis, 2012, 983640. doi:10.1155/2012/983640</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/983640</ArticleId>
            <ArticleId IdType="pmc">PMC3432348</ArticleId>
            <ArticleId IdType="pubmed">22957298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, Beauvais A, Schneider BL, &amp; Kothary R (2020). Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy. J Neuromuscul Dis, 7(3), 315–322. doi:10.3233/JND-200493</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JND-200493</ArticleId>
            <ArticleId IdType="pubmed">32333548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, De Repentigny Y, McFall E, Auclair N, Sad S, &amp; Kothary R (2017). Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum Mol Genet, 26(4), 801–819. doi:10.1093/hmg/ddw434</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw434</ArticleId>
            <ArticleId IdType="pmc">PMC5409095</ArticleId>
            <ArticleId IdType="pubmed">28108555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, … Kothary R (2020). Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy. EBioMedicine, 55, 102750. doi:10.1016/j.ebiom.2020.102750</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.102750</ArticleId>
            <ArticleId IdType="pmc">PMC7184161</ArticleId>
            <ArticleId IdType="pubmed">32339936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, &amp; Kothary R (2017). New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. Ann Clin Transl Neurol, 4(7), 522–530. doi:10.1002/acn3.423</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acn3.423</ArticleId>
            <ArticleId IdType="pmc">PMC5497530</ArticleId>
            <ArticleId IdType="pubmed">28695153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiDonato CJ, Lorson CL, De Repentigny Y, Simard L, Chartrand C, Androphy EJ, &amp; Kothary R (2001). Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet, 10(23), 2727–2736. doi:10.1093/hmg/10.23.2727</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/10.23.2727</ArticleId>
            <ArticleId IdType="pubmed">11726560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dräger NM, Sattler SM, Huang CT-L, Teter OM, Leng K, Hashemi SH, … Kampmann M (2021). A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states. bioRxiv, 2021.2006.2016.448639. doi:10.1101/2021.06.16.448639</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2021.06.16.448639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eshraghi M, McFall E, Gibeault S, &amp; Kothary R (2016). Effect of genetic background on the phenotype of the Smn2B/− mouse model of spinal muscular atrophy. Hum Mol Genet, 25(20), 4494–4506. doi:10.1093/hmg/ddw278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw278</ArticleId>
            <ArticleId IdType="pmc">PMC5409218</ArticleId>
            <ArticleId IdType="pubmed">28172892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan L, &amp; Simard LR (2002). Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum Mol Genet, 11(14), 1605–1614. doi:10.1093/hmg/11.14.1605</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/11.14.1605</ArticleId>
            <ArticleId IdType="pubmed">12075005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan Y, Xie L, &amp; Chung CY (2017). Signaling Pathways Controlling Microglia Chemotaxis. Mol Cells, 40(3), 163–168. doi:10.14348/molcells.2017.0011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14348/molcells.2017.0011</ArticleId>
            <ArticleId IdType="pmc">PMC5386953</ArticleId>
            <ArticleId IdType="pubmed">28301917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandopulle MS, Prestil R, Grunseich C, Wang C, Gan L, &amp; Ward ME (2018). Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. Curr Protoc Cell Biol, 79(1), e51. doi:10.1002/cpcb.51</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpcb.51</ArticleId>
            <ArticleId IdType="pmc">PMC6993937</ArticleId>
            <ArticleId IdType="pubmed">29924488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fletcher EV, Simon CM, Pagiazitis JG, Chalif JI, Vukojicic A, Drobac E, … Mentis GZ (2017). Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat Neurosci, 20(7), 905–916. doi:10.1038/nn.4561</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.4561</ArticleId>
            <ArticleId IdType="pmc">PMC5487291</ArticleId>
            <ArticleId IdType="pubmed">28504671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita H, Tanaka J, Toku K, Tateishi N, Suzuki Y, Matsuda S, … Maeda N (1996). Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study. Glia, 18(4), 269–281. doi:10.1002/(sici)1098-1136(199612)18:4&lt;269::aid-glia2&gt;3.0.co;2-t</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(sici)1098-1136(199612)18:4&lt;269::aid-glia2&gt;3.0.co;2-t</ArticleId>
            <ArticleId IdType="pubmed">8972796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuichi K, Gao JL, Horuk R, Wada T, Kaneko S, &amp; Murphy PM (2008). Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol, 181(12), 8670–8676. doi:10.4049/jimmunol.181.12.8670</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.12.8670</ArticleId>
            <ArticleId IdType="pmc">PMC2633769</ArticleId>
            <ArticleId IdType="pubmed">19050287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Reitboeck P, Phillips A, Piers TM, Villegas-Llerena C, Butler M, Mallach A, … Pocock JM (2018). Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis. Cell Rep, 24(9), 2300–2311. doi:10.1016/j.celrep.2018.07.094</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2018.07.094</ArticleId>
            <ArticleId IdType="pmc">PMC6130048</ArticleId>
            <ArticleId IdType="pubmed">30157425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, &amp; Didonato CJ (2012). Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci, 32(11), 3818–3829. doi:10.1523/JNEUROSCI.5775-11.2012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5775-11.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3679185</ArticleId>
            <ArticleId IdType="pubmed">22423102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gombash SE, Cowley CJ, Fitzgerald JA, Iyer CC, Fried D, McGovern VL, … Foust KD (2015). SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet, 24(19), 5665. doi:10.1093/hmg/ddv292</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv292</ArticleId>
            <ArticleId IdType="pmc">PMC4840560</ArticleId>
            <ArticleId IdType="pubmed">26223459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groen EJN (2018). Future avenues for therapy development for spinal muscular atrophy. Expert Opin Drug Discov, 13(10), 899–902. doi:10.1080/17460441.2018.1514387</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17460441.2018.1514387</ArticleId>
            <ArticleId IdType="pubmed">30124076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, … Cowley SA (2017). A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. Stem Cell Reports, 8(6), 1727–1742. doi:10.1016/j.stemcr.2017.05.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2017.05.017</ArticleId>
            <ArticleId IdType="pmc">PMC5470330</ArticleId>
            <ArticleId IdType="pubmed">28591653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond TR, Marsh SE, &amp; Stevens B (2019). Immune Signaling in Neurodegeneration. Immunity, 50(4), 955–974. doi:10.1016/j.immuni.2019.03.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2019.03.016</ArticleId>
            <ArticleId IdType="pmc">PMC6822103</ArticleId>
            <ArticleId IdType="pubmed">30995509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayhurst M, Wagner AK, Cerletti M, Wagers AJ, &amp; Rubin LL
A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein. Dev Biol, 368, 323–334. doi:10.1016/j.ydbio.2012.05.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.05.037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hickman S, Izzy S, Sen P, Morsett L, &amp; El Khoury J (2018). Microglia in neurodegeneration. Nat Neurosci, 21(10), 1359–1369. doi:10.1038/s41593-018-0242-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41593-018-0242-x</ArticleId>
            <ArticleId IdType="pmc">PMC6817969</ArticleId>
            <ArticleId IdType="pubmed">30258234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, &amp; Krainer AR (2011). Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature, 478(7367), 123–126. doi:10.1038/nature10485</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10485</ArticleId>
            <ArticleId IdType="pmc">PMC3191865</ArticleId>
            <ArticleId IdType="pubmed">21979052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khairallah MT, Astroski J, Custer SK, Androphy EJ, Franklin CL, &amp; Lorson CL (2017). SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. Hum Mol Genet, 26(5), 932–941. doi:10.1093/hmg/ddx008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx008</ArticleId>
            <ArticleId IdType="pmc">PMC6075362</ArticleId>
            <ArticleId IdType="pubmed">28062667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khayrullina G, Moritz KE, Schooley JF, Fatima N, Viollet C, McCormack NM, … Burnett BG (2020). SMN-deficiency disrupts SERCA2 expression and intracellular Ca(2+) signaling in cardiomyocytes from SMA mice and patient-derived iPSCs. Skelet Muscle, 10(1), 16. doi:10.1186/s13395-020-00232-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13395-020-00232-7</ArticleId>
            <ArticleId IdType="pmc">PMC7206821</ArticleId>
            <ArticleId IdType="pubmed">32384912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, &amp; Keane RW (2014). Pattern recognition receptors and central nervous system repair. Exp Neurol, 258, 5–16. doi:10.1016/j.expneurol.2014.01.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2014.01.001</ArticleId>
            <ArticleId IdType="pmc">PMC4974939</ArticleId>
            <ArticleId IdType="pubmed">25017883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SM, Mun BR, Lee SJ, Joh Y, Lee HY, Ji KY, … Kang HS (2017). TREM2 promotes Abeta phagocytosis by upregulating C/EBPalpha-dependent CD36 expression in microglia. Sci Rep, 7(1), 11118. doi:10.1038/s41598-017-11634-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-11634-x</ArticleId>
            <ArticleId IdType="pmc">PMC5593901</ArticleId>
            <ArticleId IdType="pubmed">28894284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolb SJ, Battle DJ, &amp; Dreyfuss G (2007). Molecular functions of the SMN complex. J Child Neurol, 22(8), 990–994. doi:10.1177/0883073807305666</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0883073807305666</ArticleId>
            <ArticleId IdType="pubmed">17761654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozlowski C, &amp; Weimer RM (2012). An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS One, 7(2), e31814. doi:10.1371/journal.pone.0031814</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0031814</ArticleId>
            <ArticleId IdType="pmc">PMC3294422</ArticleId>
            <ArticleId IdType="pubmed">22457705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, … Burghes AH (2005). SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet, 14(6), 845–857. doi:10.1093/hmg/ddi078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddi078</ArticleId>
            <ArticleId IdType="pubmed">15703193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, … et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80(1), 155–165. doi:10.1016/0092-8674(95)90460-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(95)90460-3</ArticleId>
            <ArticleId IdType="pubmed">7813012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, &amp; Barres BA (2018). Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol, 18(4), 225–242. doi:10.1038/nri.2017.125</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.125</ArticleId>
            <ArticleId IdType="pubmed">29151590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, &amp; Zheng H (2016). Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer’s Disease. J Neurosci, 36(2), 577–589. doi:10.1523/JNEUROSCI.2117-15.2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2117-15.2016</ArticleId>
            <ArticleId IdType="pmc">PMC4710776</ArticleId>
            <ArticleId IdType="pubmed">26758846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling KK, Lin MY, Zingg B, Feng Z, &amp; Ko CP (2010). Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One, 5(11), e15457. doi:10.1371/journal.pone.0015457</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0015457</ArticleId>
            <ArticleId IdType="pmc">PMC2978709</ArticleId>
            <ArticleId IdType="pubmed">21085654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Fischer U, Wang F, &amp; Dreyfuss G (1997). The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell, 90(6), 1013–1021. doi:10.1016/s0092-8674(00)80367-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(00)80367-0</ArticleId>
            <ArticleId IdType="pubmed">9323129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lively S, &amp; Schlichter LC (2013). The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation, 10, 75. doi:10.1186/1742-2094-10-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-10-75</ArticleId>
            <ArticleId IdType="pmc">PMC3693964</ArticleId>
            <ArticleId IdType="pubmed">23786632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoRusso E, Hickman JJ, &amp; Guo X (2019). Ion channel dysfunction and altered motoneuron excitability in ALS. Neurol Disord Epilepsy J, 3(2).</Citation>
        </Reference>
        <Reference>
          <Citation>Machado-Santos J, Saji E, Troscher AR, Paunovic M, Liblau R, Gabriely G, … Lassmann H (2018). The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. BRAIN, 141(7), 2066–2082. doi:10.1093/brain/awy151</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awy151</ArticleId>
            <ArticleId IdType="pmc">PMC6022681</ArticleId>
            <ArticleId IdType="pubmed">29873694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin JE, Nguyen TT, Grunseich C, Nofziger JH, Lee PR, Fields D, … Foran E (2017). Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion. J Neurosci, 37(21), 5309–5318. doi:10.1523/JNEUROSCI.3472-16.2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3472-16.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5456111</ArticleId>
            <ArticleId IdType="pubmed">28450545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massenet S, Pellizzoni L, Paushkin S, Mattaj IW, &amp; Dreyfuss G (2002). The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. Mol Cell Biol, 22(18), 6533–6541. doi:10.1128/MCB.22.18.6533-6541.2002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.22.18.6533-6541.2002</ArticleId>
            <ArticleId IdType="pmc">PMC135628</ArticleId>
            <ArticleId IdType="pubmed">12192051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCormack NM, Villalon E, Viollet C, Soltis AR, Dalgard CL, Lorson CL, &amp; Burnett BG (2021). Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression. J Cachexia Sarcopenia Muscle, 12(4), 1098–1116. doi:10.1002/jcsm.12740</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcsm.12740</ArticleId>
            <ArticleId IdType="pmc">PMC8350220</ArticleId>
            <ArticleId IdType="pubmed">34115448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McWhorter ML, Monani UR, Burghes AH, &amp; Beattie CE (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol, 162(5), 919–931. doi:10.1083/jcb.200303168</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200303168</ArticleId>
            <ArticleId IdType="pmc">PMC1761110</ArticleId>
            <ArticleId IdType="pubmed">12952942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, … Kaspar BK (2017). Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med, 377(18), 1713–1722. doi:10.1056/NEJMoa1706198</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1706198</ArticleId>
            <ArticleId IdType="pubmed">29091557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menke LA, Poll-The BT, Clur SA, Bilardo CM, van der Wal AC, Lemmink HH, &amp; Cobben JM (2008). Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am J Med Genet A, 146A(6), 740–744. doi:10.1002/ajmg.a.32233</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.32233</ArticleId>
            <ArticleId IdType="pubmed">18266240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentis GZ, Blivis D, Liu W, Drobac E, Crowder ME, Kong L, … O’Donovan MJ (2011). Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron, 69(3), 453–467. doi:10.1016/j.neuron.2010.12.032</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2010.12.032</ArticleId>
            <ArticleId IdType="pmc">PMC3044334</ArticleId>
            <ArticleId IdType="pubmed">21315257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, … Group CS (2018). Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N Engl J Med, 378(7), 625–635. doi:10.1056/NEJMoa1710504</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1710504</ArticleId>
            <ArticleId IdType="pubmed">29443664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messina S, &amp; Sframeli M (2020). New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. J Clin Med, 9(7). doi:10.3390/jcm9072222</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9072222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, &amp; Thomas PD (2019). Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc, 14(3), 703–721. doi:10.1038/s41596-019-0128-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41596-019-0128-8</ArticleId>
            <ArticleId IdType="pmc">PMC6519457</ArticleId>
            <ArticleId IdType="pubmed">30804569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mietelska-Porowska A, &amp; Wojda U (2017). T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers. J Immunol Res, 2017, 4626540. doi:10.1155/2017/4626540</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/4626540</ArticleId>
            <ArticleId IdType="pmc">PMC5331319</ArticleId>
            <ArticleId IdType="pubmed">28293644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, &amp; Papaioannou VE (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell, 68(5), 869–877. doi:10.1016/0092-8674(92)90030-g</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(92)90030-g</ArticleId>
            <ArticleId IdType="pubmed">1547488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monani UR (2005). Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron, 48(6), 885–896. doi:10.1016/j.neuron.2005.12.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2005.12.001</ArticleId>
            <ArticleId IdType="pubmed">16364894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moritz KE, McCormack NM, Abera MB, Viollet C, Yauger YJ, Sukumar G, … Burnett BG (2017). The role of the immunoproteasome in interferon-gamma-mediated microglial activation. Sci Rep, 7(1), 9365. doi:10.1038/s41598-017-09715-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-09715-y</ArticleId>
            <ArticleId IdType="pmc">PMC5571106</ArticleId>
            <ArticleId IdType="pubmed">28839214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noris M, &amp; Remuzzi G (2013). Overview of complement activation and regulation. Semin Nephrol, 33(6), 479–492. doi:10.1016/j.semnephrol.2013.08.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semnephrol.2013.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC3820029</ArticleId>
            <ArticleId IdType="pubmed">24161035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Meara RW, Cummings SE, De Repentigny Y, McFall E, Michalski JP, Deguise MO, … Kothary R (2017). Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy. Hum Mol Genet, 26(2), 282–292. doi:10.1093/hmg/ddw385</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw385</ArticleId>
            <ArticleId IdType="pubmed">28069797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohuchi K, Funato M, Ando S, Inagaki S, Sato A, Kawase C, … Hara H (2019). Impairment of oligodendrocyte lineages in spinal muscular atrophy model systems. Neuroreport, 30(5), 350–357. doi:10.1097/WNR.0000000000001206</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WNR.0000000000001206</ArticleId>
            <ArticleId IdType="pubmed">30724851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, &amp; Monani UR (2010). Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci, 30(36), 12005–12019. doi:10.1523/JNEUROSCI.2208-10.2010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2208-10.2010</ArticleId>
            <ArticleId IdType="pmc">PMC2944776</ArticleId>
            <ArticleId IdType="pubmed">20826664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patitucci TN, &amp; Ebert AD (2016). SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons. Hum Mol Genet, 25(3), 514–523. doi:10.1093/hmg/ddv489</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv489</ArticleId>
            <ArticleId IdType="pubmed">26643950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paushkin S, Gubitz AK, Massenet S, &amp; Dreyfuss G (2002). The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol, 14(3), 305–312. doi:10.1016/s0955-0674(02)00332-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0955-0674(02)00332-0</ArticleId>
            <ArticleId IdType="pubmed">12067652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellizzoni L, Charroux B, &amp; Dreyfuss G (1999). SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci U S A, 96(20), 11167–11172. doi:10.1073/pnas.96.20.11167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.20.11167</ArticleId>
            <ArticleId IdType="pmc">PMC18005</ArticleId>
            <ArticleId IdType="pubmed">10500148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellizzoni L, Kataoka N, Charroux B, &amp; Dreyfuss G (1998). A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell, 95(5), 615–624. doi:10.1016/s0092-8674(00)81632-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(00)81632-3</ArticleId>
            <ArticleId IdType="pubmed">9845364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, &amp; Kedl RM (2013). T cell responses: naive to memory and everything in between. Adv Physiol Educ, 37(4), 273–283. doi:10.1152/advan.00066.2013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/advan.00066.2013</ArticleId>
            <ArticleId IdType="pmc">PMC4089090</ArticleId>
            <ArticleId IdType="pubmed">24292902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto-Costa R, &amp; Sousa MM (2020). Profilin as a dual regulator of actin and microtubule dynamics. Cytoskeleton (Hoboken), 77(3–4), 76–83. doi:10.1002/cm.21586</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cm.21586</ArticleId>
            <ArticleId IdType="pubmed">31811707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quinlan KA, Reedich EJ, Arnold WD, Puritz AC, Cavarsan CF, Heckman CJ, &amp; DiDonato CJ (2019). Hyperexcitability precedes motoneuron loss in the Smn(2B/−) mouse model of spinal muscular atrophy. J Neurophysiol, 122(4), 1297–1311. doi:10.1152/jn.00652.2018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.00652.2018</ArticleId>
            <ArticleId IdType="pmc">PMC6843095</ArticleId>
            <ArticleId IdType="pubmed">31365319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahemtulla A, Fung-Leung WP, Schilham MW, Kundig TM, Sambhara SR, Narendran A, … et al. (1991). Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature, 353(6340), 180–184. doi:10.1038/353180a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/353180a0</ArticleId>
            <ArticleId IdType="pubmed">1832488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rezai-Zadeh K, Gate D, &amp; Town T (2009). CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?
J Neuroimmune Pharmacol, 4(4), 462–475. doi:10.1007/s11481-009-9166-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11481-009-9166-2</ArticleId>
            <ArticleId IdType="pmc">PMC2773117</ArticleId>
            <ArticleId IdType="pubmed">19669892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, … Lorson CL (2015). Astrocytes influence the severity of spinal muscular atrophy. Hum Mol Genet, 24(14), 4094–4102. doi:10.1093/hmg/ddv148</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv148</ArticleId>
            <ArticleId IdType="pmc">PMC5007659</ArticleId>
            <ArticleId IdType="pubmed">25911676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roos M, Sarkozy A, Chierchia GB, De Wilde P, Schmedding E, &amp; Brugada P (2009). Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease). J Cardiovasc Electrophysiol, 20(3), 342–344. doi:10.1111/j.1540-8167.2008.01327.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1540-8167.2008.01327.x</ArticleId>
            <ArticleId IdType="pubmed">19175839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, &amp; Sendtner M (2003). Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol, 163(4), 801–812. doi:10.1083/jcb.200304128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200304128</ArticleId>
            <ArticleId IdType="pmc">PMC2173668</ArticleId>
            <ArticleId IdType="pubmed">14623865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenten D, &amp; Medzhitov R (2011). The control of adaptive immune responses by the innate immune system. Adv Immunol, 109, 87–124. doi:10.1016/B978-0-12-387664-5.00003-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-12-387664-5.00003-0</ArticleId>
            <ArticleId IdType="pubmed">21569913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, &amp; Van Kooyk Y (2017). Neuroinflammation: Microglia and T Cells Get Ready to Tango. Front Immunol, 8, 1905. doi:10.3389/fimmu.2017.01905</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01905</ArticleId>
            <ArticleId IdType="pmc">PMC5788906</ArticleId>
            <ArticleId IdType="pubmed">29422891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shafey D, Cote PD, &amp; Kothary R (2005). Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res, 311(1), 49–61. doi:10.1016/j.yexcr.2005.08.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2005.08.019</ArticleId>
            <ArticleId IdType="pubmed">16219305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon CM, Dai Y, Van Alstyne M, Koutsioumpa C, Pagiazitis JG, Chalif JI, … Mentis GZ (2017). Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy. Cell Rep, 21(13), 3767–3780. doi:10.1016/j.celrep.2017.12.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.12.003</ArticleId>
            <ArticleId IdType="pmc">PMC5747328</ArticleId>
            <ArticleId IdType="pubmed">29281826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D, … Corti S (2016). Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?
Cell Mol Life Sci, 73(5), 1003–1020. doi:10.1007/s00018-015-2106-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-015-2106-9</ArticleId>
            <ArticleId IdType="pmc">PMC4756905</ArticleId>
            <ArticleId IdType="pubmed">26681261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sison SL, Patitucci TN, Seminary ER, Villalon E, Lorson CL, &amp; Ebert AD (2017). Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Hum Mol Genet, 26(17), 3409–3420. doi:10.1093/hmg/ddx230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx230</ArticleId>
            <ArticleId IdType="pubmed">28637335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun J, &amp; Harrington MA (2019). The Alteration of Intrinsic Excitability and Synaptic Transmission in Lumbar Spinal Motor Neurons and Interneurons of Severe Spinal Muscular Atrophy Mice. Front Cell Neurosci, 13, 15. doi:10.3389/fncel.2019.00015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2019.00015</ArticleId>
            <ArticleId IdType="pmc">PMC6374350</ArticleId>
            <ArticleId IdType="pubmed">30792629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, &amp; Bromberg MB (2005). Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol, 57(5), 704–712. doi:10.1002/ana.20473</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.20473</ArticleId>
            <ArticleId IdType="pmc">PMC4334582</ArticleId>
            <ArticleId IdType="pubmed">15852397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarabal O, Caraballo-Miralles V, Cardona-Rossinyol A, Correa FJ, Olmos G, Llado J, … Caldero J (2014). Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. J Neuropathol Exp Neurol, 73(6), 519–535. doi:10.1097/NEN.0000000000000074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/NEN.0000000000000074</ArticleId>
            <ArticleId IdType="pubmed">24806302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor AS, Glascock JJ, Rose FF Jr., Lutz C, &amp; Lorson CL (2013). Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy. Transgenic Res, 22(5), 1029–1036. doi:10.1007/s11248-013-9702-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11248-013-9702-y</ArticleId>
            <ArticleId IdType="pmc">PMC3745810</ArticleId>
            <ArticleId IdType="pubmed">23512182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomson SR, Nahon JE, Mutsaers CA, Thomson D, Hamilton G, Parson SH, &amp; Gillingwater TH (2012). Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One, 7(12), e52605. doi:10.1371/journal.pone.0052605</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0052605</ArticleId>
            <ArticleId IdType="pmc">PMC3527597</ArticleId>
            <ArticleId IdType="pubmed">23285108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venereau E, Ceriotti C, &amp; Bianchi ME (2015). DAMPs from Cell Death to New Life. Front Immunol, 6, 422. doi:10.3389/fimmu.2015.00422</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2015.00422</ArticleId>
            <ArticleId IdType="pmc">PMC4539554</ArticleId>
            <ArticleId IdType="pubmed">26347745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vukojicic A, Delestree N, Fletcher EV, Pagiazitis JG, Sankaranarayanan S, Yednock TA, … G. Z. Mentis (2019). The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA. Cell Rep, 29(10), 3087–3100 e3087. doi:10.1016/j.celrep.2019.11.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.11.013</ArticleId>
            <ArticleId IdType="pmc">PMC6937140</ArticleId>
            <ArticleId IdType="pubmed">31801075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan B, Feng P, Guan Z, Sheng L, Liu Z, &amp; Hua Y (2018). A severe mouse model of spinal muscular atrophy develops early systemic inflammation. Hum Mol Genet, 27(23), 4061–4076. doi:10.1093/hmg/ddy300</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddy300</ArticleId>
            <ArticleId IdType="pubmed">30137324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao H, Coppola K, Schweig JE, Crawford F, Mullan M, &amp; Paris D (2019). Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFkappaB Antagonistic Activities. Front Cell Neurosci, 13, 457. doi:10.3389/fncel.2019.00457</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2019.00457</ArticleId>
            <ArticleId IdType="pmc">PMC6795686</ArticleId>
            <ArticleId IdType="pubmed">31649511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yong J, Wan L, &amp; Dreyfuss G (2004). Why do cells need an assembly machine for RNA-protein complexes?
Trends Cell Biol, 14(5), 226–232. doi:10.1016/j.tcb.2004.03.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2004.03.010</ArticleId>
            <ArticleId IdType="pubmed">15130578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zabel MK, &amp; Kirsch WM (2013). From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev, 12(3), 749–756. doi:10.1016/j.arr.2013.02.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arr.2013.02.001</ArticleId>
            <ArticleId IdType="pmc">PMC3700678</ArticleId>
            <ArticleId IdType="pubmed">23419464</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35373853</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-1136</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>70</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Glia</Title>
          <ISOAbbreviation>Glia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Survival motor neuron protein deficiency alters microglia reactivity.</ArticleTitle>
        <Pagination>
          <StartPage>1337</StartPage>
          <EndPage>1358</EndPage>
          <MedlinePgn>1337-1358</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.24177</ELocationID>
        <Abstract>
          <AbstractText>Survival motor neuron (SMN) protein deficiency results in loss of alpha motor neurons and subsequent muscle atrophy in patients with spinal muscular atrophy (SMA). Reactive microglia have been reported in SMA mice and depleting microglia rescues the number of proprioceptive synapses, suggesting a role in SMA pathology. Here, we explore the contribution of lymphocytes on microglia reactivity in SMA mice and investigate how SMN deficiency alters the reactive profile of human induced pluripotent stem cell (iPSC)-derived microglia. We show that microglia adopt a reactive morphology in spinal cords of SMA mice. Ablating lymphocytes did not alter the reactive morphology of SMA microglia and did not improve the survival or motor function of SMA mice, indicating limited impact of peripheral immune cells on the SMA phenotype. We found iPSC-derived SMA microglia adopted an amoeboid morphology and displayed a reactive transcriptome profile, increased cell migration, and enhanced phagocytic activity. Importantly, cell morphology and electrophysiological properties of motor neurons were altered when they were incubated with conditioned media from SMA microglia. Together, these data reveal that SMN-deficient microglia adopt a reactive profile and exhibit an exaggerated inflammatory response with potential impact on SMA neuropathology.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. GLIA published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Khayrullina</LastName>
            <ForeName>Guzal</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alipio-Gloria</LastName>
            <ForeName>Zaida A</ForeName>
            <Initials>ZA</Initials>
            <AffiliationInfo>
              <Affiliation>Calibr, Scripps Research Institute, La Jolla, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deguise</LastName>
            <ForeName>Marc-Olivier</ForeName>
            <Initials>MO</Initials>
            <Identifier Source="ORCID">0000-0002-3802-1195</Identifier>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gagnon</LastName>
            <ForeName>Sabrina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chehade</LastName>
            <ForeName>Lucia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stinson</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belous</LastName>
            <ForeName>Natalya</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bergman</LastName>
            <ForeName>Elizabeth M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lischka</LastName>
            <ForeName>Fritz W</ForeName>
            <Initials>FW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rotty</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dalgard</LastName>
            <ForeName>Clifton L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kothary</LastName>
            <ForeName>Rashmi</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-9239-7310</Identifier>
            <AffiliationInfo>
              <Affiliation>Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Neuromuscular Disease, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnson</LastName>
            <ForeName>Kristen A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Calibr, Scripps Research Institute, La Jolla, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burnett</LastName>
            <ForeName>Barrington G</ForeName>
            <Initials>BG</Initials>
            <Identifier Source="ORCID">0000-0002-5001-3358</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>PJT-156379</GrantID>
            <Acronym>CAPMC</Acronym>
            <Agency> CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>R01NS091575</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 GM134104</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>RO1GM134104</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS094721</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS091575</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS119594</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01NS094721</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Glia</MedlineTA>
        <NlmUniqueID>8806785</NlmUniqueID>
        <ISSNLinking>0894-1491</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D055533">Survival of Motor Neuron 1 Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011488" MajorTopicYN="Y">Protein Deficiency</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055533" MajorTopicYN="N">Survival of Motor Neuron 1 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">induced pluripotent stem cell</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">microglia</Keyword>
        <Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword>
        <Keyword MajorTopicYN="N">survival motor neuron</Keyword>
      </KeywordList>
      <CoiStatement>Competing Interests. Neither I nor my family members have a financial interest in any commercial product, service, or organization providing financial support for this research.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>8</Hour>
          <Minute>43</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35373853</ArticleId>
        <ArticleId IdType="mid">NIHMS1793183</ArticleId>
        <ArticleId IdType="pmc">PMC9081169</ArticleId>
        <ArticleId IdType="doi">10.1002/glia.24177</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Akten B, Kye MJ, Hao le T, Wertz MH, Singh S, Nie D, … Sahin M (2011). Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc Natl Acad Sci U S A, 108(25), 10337–10342. doi:10.1073/pnas.1104928108</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1104928108</ArticleId>
            <ArticleId IdType="pmc">PMC3121858</ArticleId>
            <ArticleId IdType="pubmed">21652774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alliot F, Godin I, &amp; Pessac B (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res, 117(2), 145–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10567732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ando S, Osanai D, Takahashi K, Nakamura S, Shimazawa M, &amp; Hara H (2020). Survival motor neuron protein regulates oxidative stress and inflammatory response in microglia of the spinal cord in spinal muscular atrophy. J Pharmacol Sci, 144(4), 204–211. doi:10.1016/j.jphs.2020.09.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jphs.2020.09.001</ArticleId>
            <ArticleId IdType="pubmed">33070839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arumugam S, Garcera A, Soler RM, &amp; Tabares L (2017). Smn-Deficiency Increases the Intrinsic Excitability of Motoneurons. Front Cell Neurosci, 11, 269. doi:10.3389/fncel.2017.00269</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2017.00269</ArticleId>
            <ArticleId IdType="pmc">PMC5591959</ArticleId>
            <ArticleId IdType="pubmed">28928636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanquie O, &amp; Bradke F (2018). Cytoskeleton dynamics in axon regeneration. Curr Opin Neurobiol, 51, 60–69. doi:10.1016/j.conb.2018.02.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.conb.2018.02.024</ArticleId>
            <ArticleId IdType="pubmed">29544200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowerman M, Murray LM, Beauvais A, Pinheiro B, &amp; Kothary R (2012). A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul Disord, 22(3), 263–276. doi:10.1016/j.nmd.2011.09.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2011.09.007</ArticleId>
            <ArticleId IdType="pubmed">22071333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowerman M, Shafey D, &amp; Kothary R (2007). Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J Mol Neurosci, 32(2), 120–131. doi:10.1007/s12031-007-0024-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-007-0024-5</ArticleId>
            <ArticleId IdType="pubmed">17873296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyer JG, Deguise MO, Murray LM, Yazdani A, De Repentigny Y, Boudreau-Lariviere C, &amp; Kothary R (2014). Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. Hum Mol Genet, 23(16), 4249–4259. doi:10.1093/hmg/ddu142</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu142</ArticleId>
            <ArticleId IdType="pmc">PMC4103674</ArticleId>
            <ArticleId IdType="pubmed">24691550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bricceno KV, Martinez T, Leikina E, Duguez S, Partridge TA, Chernomordik LV, … Burnett BG (2014). Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Hum Mol Genet, 23(18), 4745–4757. doi:10.1093/hmg/ddu189</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu189</ArticleId>
            <ArticleId IdType="pmc">PMC4140458</ArticleId>
            <ArticleId IdType="pubmed">24760765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, … Hunot S (2009). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest, 119(1), 182–192. doi:10.1172/JCI36470</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI36470</ArticleId>
            <ArticleId IdType="pmc">PMC2613467</ArticleId>
            <ArticleId IdType="pubmed">19104149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burghes AH, &amp; Beattie CE (2009). Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Nat Rev Neurosci, 10(8), 597–609. doi:10.1038/nrn2670</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn2670</ArticleId>
            <ArticleId IdType="pmc">PMC2853768</ArticleId>
            <ArticleId IdType="pubmed">19584893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervero C, Blasco A, Tarabal O, Casanovas A, Piedrafita L, Navarro X, … Caldero J (2018). Glial Activation and Central Synapse Loss, but Not Motoneuron Degeneration, Are Prevented by the Sigma-1 Receptor Agonist PRE-084 in the Smn2B/− Mouse Model of Spinal Muscular Atrophy. J Neuropathol Exp Neurol, 77(7), 577–597. doi:10.1093/jnen/nly033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jnen/nly033</ArticleId>
            <ArticleId IdType="pubmed">29767748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaplin DD (2010). Overview of the immune response. J Allergy Clin Immunol, 125(2 Suppl 2), S3–23. doi:10.1016/j.jaci.2009.12.980</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2009.12.980</ArticleId>
            <ArticleId IdType="pmc">PMC2923430</ArticleId>
            <ArticleId IdType="pubmed">20176265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaytow H, Huang YT, Gillingwater TH, &amp; Faller KME (2018). The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci, 75(21), 3877–3894. doi:10.1007/s00018-018-2849-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-018-2849-1</ArticleId>
            <ArticleId IdType="pmc">PMC6182345</ArticleId>
            <ArticleId IdType="pubmed">29872871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, … Luster AD (2010). Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity, 33(2), 266–278. doi:10.1016/j.immuni.2010.07.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2010.07.018</ArticleId>
            <ArticleId IdType="pmc">PMC3155777</ArticleId>
            <ArticleId IdType="pubmed">20727790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crehan H, Hardy J, &amp; Pocock J (2012). Microglia, Alzheimer’s disease, and complement. Int J Alzheimers Dis, 2012, 983640. doi:10.1155/2012/983640</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/983640</ArticleId>
            <ArticleId IdType="pmc">PMC3432348</ArticleId>
            <ArticleId IdType="pubmed">22957298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, Beauvais A, Schneider BL, &amp; Kothary R (2020). Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy. J Neuromuscul Dis, 7(3), 315–322. doi:10.3233/JND-200493</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JND-200493</ArticleId>
            <ArticleId IdType="pubmed">32333548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, De Repentigny Y, McFall E, Auclair N, Sad S, &amp; Kothary R (2017). Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum Mol Genet, 26(4), 801–819. doi:10.1093/hmg/ddw434</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw434</ArticleId>
            <ArticleId IdType="pmc">PMC5409095</ArticleId>
            <ArticleId IdType="pubmed">28108555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, … Kothary R (2020). Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy. EBioMedicine, 55, 102750. doi:10.1016/j.ebiom.2020.102750</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.102750</ArticleId>
            <ArticleId IdType="pmc">PMC7184161</ArticleId>
            <ArticleId IdType="pubmed">32339936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguise MO, &amp; Kothary R (2017). New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. Ann Clin Transl Neurol, 4(7), 522–530. doi:10.1002/acn3.423</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acn3.423</ArticleId>
            <ArticleId IdType="pmc">PMC5497530</ArticleId>
            <ArticleId IdType="pubmed">28695153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiDonato CJ, Lorson CL, De Repentigny Y, Simard L, Chartrand C, Androphy EJ, &amp; Kothary R (2001). Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet, 10(23), 2727–2736. doi:10.1093/hmg/10.23.2727</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/10.23.2727</ArticleId>
            <ArticleId IdType="pubmed">11726560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dräger NM, Sattler SM, Huang CT-L, Teter OM, Leng K, Hashemi SH, … Kampmann M (2021). A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states. bioRxiv, 2021.2006.2016.448639. doi:10.1101/2021.06.16.448639</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2021.06.16.448639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eshraghi M, McFall E, Gibeault S, &amp; Kothary R (2016). Effect of genetic background on the phenotype of the Smn2B/− mouse model of spinal muscular atrophy. Hum Mol Genet, 25(20), 4494–4506. doi:10.1093/hmg/ddw278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw278</ArticleId>
            <ArticleId IdType="pmc">PMC5409218</ArticleId>
            <ArticleId IdType="pubmed">28172892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan L, &amp; Simard LR (2002). Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum Mol Genet, 11(14), 1605–1614. doi:10.1093/hmg/11.14.1605</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/11.14.1605</ArticleId>
            <ArticleId IdType="pubmed">12075005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan Y, Xie L, &amp; Chung CY (2017). Signaling Pathways Controlling Microglia Chemotaxis. Mol Cells, 40(3), 163–168. doi:10.14348/molcells.2017.0011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14348/molcells.2017.0011</ArticleId>
            <ArticleId IdType="pmc">PMC5386953</ArticleId>
            <ArticleId IdType="pubmed">28301917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandopulle MS, Prestil R, Grunseich C, Wang C, Gan L, &amp; Ward ME (2018). Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. Curr Protoc Cell Biol, 79(1), e51. doi:10.1002/cpcb.51</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpcb.51</ArticleId>
            <ArticleId IdType="pmc">PMC6993937</ArticleId>
            <ArticleId IdType="pubmed">29924488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fletcher EV, Simon CM, Pagiazitis JG, Chalif JI, Vukojicic A, Drobac E, … Mentis GZ (2017). Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat Neurosci, 20(7), 905–916. doi:10.1038/nn.4561</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.4561</ArticleId>
            <ArticleId IdType="pmc">PMC5487291</ArticleId>
            <ArticleId IdType="pubmed">28504671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita H, Tanaka J, Toku K, Tateishi N, Suzuki Y, Matsuda S, … Maeda N (1996). Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study. Glia, 18(4), 269–281. doi:10.1002/(sici)1098-1136(199612)18:4&lt;269::aid-glia2&gt;3.0.co;2-t</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(sici)1098-1136(199612)18:4&lt;269::aid-glia2&gt;3.0.co;2-t</ArticleId>
            <ArticleId IdType="pubmed">8972796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuichi K, Gao JL, Horuk R, Wada T, Kaneko S, &amp; Murphy PM (2008). Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol, 181(12), 8670–8676. doi:10.4049/jimmunol.181.12.8670</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.12.8670</ArticleId>
            <ArticleId IdType="pmc">PMC2633769</ArticleId>
            <ArticleId IdType="pubmed">19050287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Reitboeck P, Phillips A, Piers TM, Villegas-Llerena C, Butler M, Mallach A, … Pocock JM (2018). Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis. Cell Rep, 24(9), 2300–2311. doi:10.1016/j.celrep.2018.07.094</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2018.07.094</ArticleId>
            <ArticleId IdType="pmc">PMC6130048</ArticleId>
            <ArticleId IdType="pubmed">30157425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, &amp; Didonato CJ (2012). Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci, 32(11), 3818–3829. doi:10.1523/JNEUROSCI.5775-11.2012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5775-11.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3679185</ArticleId>
            <ArticleId IdType="pubmed">22423102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gombash SE, Cowley CJ, Fitzgerald JA, Iyer CC, Fried D, McGovern VL, … Foust KD (2015). SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet, 24(19), 5665. doi:10.1093/hmg/ddv292</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv292</ArticleId>
            <ArticleId IdType="pmc">PMC4840560</ArticleId>
            <ArticleId IdType="pubmed">26223459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groen EJN (2018). Future avenues for therapy development for spinal muscular atrophy. Expert Opin Drug Discov, 13(10), 899–902. doi:10.1080/17460441.2018.1514387</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17460441.2018.1514387</ArticleId>
            <ArticleId IdType="pubmed">30124076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, … Cowley SA (2017). A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. Stem Cell Reports, 8(6), 1727–1742. doi:10.1016/j.stemcr.2017.05.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2017.05.017</ArticleId>
            <ArticleId IdType="pmc">PMC5470330</ArticleId>
            <ArticleId IdType="pubmed">28591653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond TR, Marsh SE, &amp; Stevens B (2019). Immune Signaling in Neurodegeneration. Immunity, 50(4), 955–974. doi:10.1016/j.immuni.2019.03.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2019.03.016</ArticleId>
            <ArticleId IdType="pmc">PMC6822103</ArticleId>
            <ArticleId IdType="pubmed">30995509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayhurst M, Wagner AK, Cerletti M, Wagers AJ, &amp; Rubin LL
A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein. Dev Biol, 368, 323–334. doi:10.1016/j.ydbio.2012.05.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.05.037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hickman S, Izzy S, Sen P, Morsett L, &amp; El Khoury J (2018). Microglia in neurodegeneration. Nat Neurosci, 21(10), 1359–1369. doi:10.1038/s41593-018-0242-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41593-018-0242-x</ArticleId>
            <ArticleId IdType="pmc">PMC6817969</ArticleId>
            <ArticleId IdType="pubmed">30258234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, &amp; Krainer AR (2011). Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature, 478(7367), 123–126. doi:10.1038/nature10485</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10485</ArticleId>
            <ArticleId IdType="pmc">PMC3191865</ArticleId>
            <ArticleId IdType="pubmed">21979052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khairallah MT, Astroski J, Custer SK, Androphy EJ, Franklin CL, &amp; Lorson CL (2017). SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. Hum Mol Genet, 26(5), 932–941. doi:10.1093/hmg/ddx008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx008</ArticleId>
            <ArticleId IdType="pmc">PMC6075362</ArticleId>
            <ArticleId IdType="pubmed">28062667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khayrullina G, Moritz KE, Schooley JF, Fatima N, Viollet C, McCormack NM, … Burnett BG (2020). SMN-deficiency disrupts SERCA2 expression and intracellular Ca(2+) signaling in cardiomyocytes from SMA mice and patient-derived iPSCs. Skelet Muscle, 10(1), 16. doi:10.1186/s13395-020-00232-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13395-020-00232-7</ArticleId>
            <ArticleId IdType="pmc">PMC7206821</ArticleId>
            <ArticleId IdType="pubmed">32384912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, &amp; Keane RW (2014). Pattern recognition receptors and central nervous system repair. Exp Neurol, 258, 5–16. doi:10.1016/j.expneurol.2014.01.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2014.01.001</ArticleId>
            <ArticleId IdType="pmc">PMC4974939</ArticleId>
            <ArticleId IdType="pubmed">25017883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SM, Mun BR, Lee SJ, Joh Y, Lee HY, Ji KY, … Kang HS (2017). TREM2 promotes Abeta phagocytosis by upregulating C/EBPalpha-dependent CD36 expression in microglia. Sci Rep, 7(1), 11118. doi:10.1038/s41598-017-11634-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-11634-x</ArticleId>
            <ArticleId IdType="pmc">PMC5593901</ArticleId>
            <ArticleId IdType="pubmed">28894284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolb SJ, Battle DJ, &amp; Dreyfuss G (2007). Molecular functions of the SMN complex. J Child Neurol, 22(8), 990–994. doi:10.1177/0883073807305666</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0883073807305666</ArticleId>
            <ArticleId IdType="pubmed">17761654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozlowski C, &amp; Weimer RM (2012). An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS One, 7(2), e31814. doi:10.1371/journal.pone.0031814</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0031814</ArticleId>
            <ArticleId IdType="pmc">PMC3294422</ArticleId>
            <ArticleId IdType="pubmed">22457705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, … Burghes AH (2005). SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet, 14(6), 845–857. doi:10.1093/hmg/ddi078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddi078</ArticleId>
            <ArticleId IdType="pubmed">15703193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, … et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80(1), 155–165. doi:10.1016/0092-8674(95)90460-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(95)90460-3</ArticleId>
            <ArticleId IdType="pubmed">7813012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, &amp; Barres BA (2018). Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol, 18(4), 225–242. doi:10.1038/nri.2017.125</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.125</ArticleId>
            <ArticleId IdType="pubmed">29151590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, &amp; Zheng H (2016). Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer’s Disease. J Neurosci, 36(2), 577–589. doi:10.1523/JNEUROSCI.2117-15.2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2117-15.2016</ArticleId>
            <ArticleId IdType="pmc">PMC4710776</ArticleId>
            <ArticleId IdType="pubmed">26758846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling KK, Lin MY, Zingg B, Feng Z, &amp; Ko CP (2010). Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One, 5(11), e15457. doi:10.1371/journal.pone.0015457</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0015457</ArticleId>
            <ArticleId IdType="pmc">PMC2978709</ArticleId>
            <ArticleId IdType="pubmed">21085654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Fischer U, Wang F, &amp; Dreyfuss G (1997). The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell, 90(6), 1013–1021. doi:10.1016/s0092-8674(00)80367-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(00)80367-0</ArticleId>
            <ArticleId IdType="pubmed">9323129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lively S, &amp; Schlichter LC (2013). The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation, 10, 75. doi:10.1186/1742-2094-10-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-10-75</ArticleId>
            <ArticleId IdType="pmc">PMC3693964</ArticleId>
            <ArticleId IdType="pubmed">23786632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoRusso E, Hickman JJ, &amp; Guo X (2019). Ion channel dysfunction and altered motoneuron excitability in ALS. Neurol Disord Epilepsy J, 3(2).</Citation>
        </Reference>
        <Reference>
          <Citation>Machado-Santos J, Saji E, Troscher AR, Paunovic M, Liblau R, Gabriely G, … Lassmann H (2018). The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. BRAIN, 141(7), 2066–2082. doi:10.1093/brain/awy151</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awy151</ArticleId>
            <ArticleId IdType="pmc">PMC6022681</ArticleId>
            <ArticleId IdType="pubmed">29873694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin JE, Nguyen TT, Grunseich C, Nofziger JH, Lee PR, Fields D, … Foran E (2017). Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion. J Neurosci, 37(21), 5309–5318. doi:10.1523/JNEUROSCI.3472-16.2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3472-16.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5456111</ArticleId>
            <ArticleId IdType="pubmed">28450545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massenet S, Pellizzoni L, Paushkin S, Mattaj IW, &amp; Dreyfuss G (2002). The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. Mol Cell Biol, 22(18), 6533–6541. doi:10.1128/MCB.22.18.6533-6541.2002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.22.18.6533-6541.2002</ArticleId>
            <ArticleId IdType="pmc">PMC135628</ArticleId>
            <ArticleId IdType="pubmed">12192051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCormack NM, Villalon E, Viollet C, Soltis AR, Dalgard CL, Lorson CL, &amp; Burnett BG (2021). Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression. J Cachexia Sarcopenia Muscle, 12(4), 1098–1116. doi:10.1002/jcsm.12740</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcsm.12740</ArticleId>
            <ArticleId IdType="pmc">PMC8350220</ArticleId>
            <ArticleId IdType="pubmed">34115448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McWhorter ML, Monani UR, Burghes AH, &amp; Beattie CE (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol, 162(5), 919–931. doi:10.1083/jcb.200303168</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200303168</ArticleId>
            <ArticleId IdType="pmc">PMC1761110</ArticleId>
            <ArticleId IdType="pubmed">12952942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, … Kaspar BK (2017). Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med, 377(18), 1713–1722. doi:10.1056/NEJMoa1706198</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1706198</ArticleId>
            <ArticleId IdType="pubmed">29091557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menke LA, Poll-The BT, Clur SA, Bilardo CM, van der Wal AC, Lemmink HH, &amp; Cobben JM (2008). Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am J Med Genet A, 146A(6), 740–744. doi:10.1002/ajmg.a.32233</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.32233</ArticleId>
            <ArticleId IdType="pubmed">18266240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentis GZ, Blivis D, Liu W, Drobac E, Crowder ME, Kong L, … O’Donovan MJ (2011). Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron, 69(3), 453–467. doi:10.1016/j.neuron.2010.12.032</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2010.12.032</ArticleId>
            <ArticleId IdType="pmc">PMC3044334</ArticleId>
            <ArticleId IdType="pubmed">21315257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, … Group CS (2018). Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N Engl J Med, 378(7), 625–635. doi:10.1056/NEJMoa1710504</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1710504</ArticleId>
            <ArticleId IdType="pubmed">29443664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messina S, &amp; Sframeli M (2020). New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. J Clin Med, 9(7). doi:10.3390/jcm9072222</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9072222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, &amp; Thomas PD (2019). Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc, 14(3), 703–721. doi:10.1038/s41596-019-0128-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41596-019-0128-8</ArticleId>
            <ArticleId IdType="pmc">PMC6519457</ArticleId>
            <ArticleId IdType="pubmed">30804569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mietelska-Porowska A, &amp; Wojda U (2017). T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers. J Immunol Res, 2017, 4626540. doi:10.1155/2017/4626540</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/4626540</ArticleId>
            <ArticleId IdType="pmc">PMC5331319</ArticleId>
            <ArticleId IdType="pubmed">28293644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, &amp; Papaioannou VE (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell, 68(5), 869–877. doi:10.1016/0092-8674(92)90030-g</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(92)90030-g</ArticleId>
            <ArticleId IdType="pubmed">1547488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monani UR (2005). Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron, 48(6), 885–896. doi:10.1016/j.neuron.2005.12.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2005.12.001</ArticleId>
            <ArticleId IdType="pubmed">16364894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moritz KE, McCormack NM, Abera MB, Viollet C, Yauger YJ, Sukumar G, … Burnett BG (2017). The role of the immunoproteasome in interferon-gamma-mediated microglial activation. Sci Rep, 7(1), 9365. doi:10.1038/s41598-017-09715-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-09715-y</ArticleId>
            <ArticleId IdType="pmc">PMC5571106</ArticleId>
            <ArticleId IdType="pubmed">28839214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noris M, &amp; Remuzzi G (2013). Overview of complement activation and regulation. Semin Nephrol, 33(6), 479–492. doi:10.1016/j.semnephrol.2013.08.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semnephrol.2013.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC3820029</ArticleId>
            <ArticleId IdType="pubmed">24161035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Meara RW, Cummings SE, De Repentigny Y, McFall E, Michalski JP, Deguise MO, … Kothary R (2017). Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy. Hum Mol Genet, 26(2), 282–292. doi:10.1093/hmg/ddw385</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddw385</ArticleId>
            <ArticleId IdType="pubmed">28069797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohuchi K, Funato M, Ando S, Inagaki S, Sato A, Kawase C, … Hara H (2019). Impairment of oligodendrocyte lineages in spinal muscular atrophy model systems. Neuroreport, 30(5), 350–357. doi:10.1097/WNR.0000000000001206</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WNR.0000000000001206</ArticleId>
            <ArticleId IdType="pubmed">30724851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, &amp; Monani UR (2010). Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci, 30(36), 12005–12019. doi:10.1523/JNEUROSCI.2208-10.2010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2208-10.2010</ArticleId>
            <ArticleId IdType="pmc">PMC2944776</ArticleId>
            <ArticleId IdType="pubmed">20826664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patitucci TN, &amp; Ebert AD (2016). SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons. Hum Mol Genet, 25(3), 514–523. doi:10.1093/hmg/ddv489</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv489</ArticleId>
            <ArticleId IdType="pubmed">26643950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paushkin S, Gubitz AK, Massenet S, &amp; Dreyfuss G (2002). The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol, 14(3), 305–312. doi:10.1016/s0955-0674(02)00332-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0955-0674(02)00332-0</ArticleId>
            <ArticleId IdType="pubmed">12067652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellizzoni L, Charroux B, &amp; Dreyfuss G (1999). SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci U S A, 96(20), 11167–11172. doi:10.1073/pnas.96.20.11167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.20.11167</ArticleId>
            <ArticleId IdType="pmc">PMC18005</ArticleId>
            <ArticleId IdType="pubmed">10500148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellizzoni L, Kataoka N, Charroux B, &amp; Dreyfuss G (1998). A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell, 95(5), 615–624. doi:10.1016/s0092-8674(00)81632-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(00)81632-3</ArticleId>
            <ArticleId IdType="pubmed">9845364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, &amp; Kedl RM (2013). T cell responses: naive to memory and everything in between. Adv Physiol Educ, 37(4), 273–283. doi:10.1152/advan.00066.2013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/advan.00066.2013</ArticleId>
            <ArticleId IdType="pmc">PMC4089090</ArticleId>
            <ArticleId IdType="pubmed">24292902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto-Costa R, &amp; Sousa MM (2020). Profilin as a dual regulator of actin and microtubule dynamics. Cytoskeleton (Hoboken), 77(3–4), 76–83. doi:10.1002/cm.21586</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cm.21586</ArticleId>
            <ArticleId IdType="pubmed">31811707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quinlan KA, Reedich EJ, Arnold WD, Puritz AC, Cavarsan CF, Heckman CJ, &amp; DiDonato CJ (2019). Hyperexcitability precedes motoneuron loss in the Smn(2B/−) mouse model of spinal muscular atrophy. J Neurophysiol, 122(4), 1297–1311. doi:10.1152/jn.00652.2018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.00652.2018</ArticleId>
            <ArticleId IdType="pmc">PMC6843095</ArticleId>
            <ArticleId IdType="pubmed">31365319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahemtulla A, Fung-Leung WP, Schilham MW, Kundig TM, Sambhara SR, Narendran A, … et al. (1991). Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature, 353(6340), 180–184. doi:10.1038/353180a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/353180a0</ArticleId>
            <ArticleId IdType="pubmed">1832488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rezai-Zadeh K, Gate D, &amp; Town T (2009). CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?
J Neuroimmune Pharmacol, 4(4), 462–475. doi:10.1007/s11481-009-9166-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11481-009-9166-2</ArticleId>
            <ArticleId IdType="pmc">PMC2773117</ArticleId>
            <ArticleId IdType="pubmed">19669892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, … Lorson CL (2015). Astrocytes influence the severity of spinal muscular atrophy. Hum Mol Genet, 24(14), 4094–4102. doi:10.1093/hmg/ddv148</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddv148</ArticleId>
            <ArticleId IdType="pmc">PMC5007659</ArticleId>
            <ArticleId IdType="pubmed">25911676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roos M, Sarkozy A, Chierchia GB, De Wilde P, Schmedding E, &amp; Brugada P (2009). Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease). J Cardiovasc Electrophysiol, 20(3), 342–344. doi:10.1111/j.1540-8167.2008.01327.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1540-8167.2008.01327.x</ArticleId>
            <ArticleId IdType="pubmed">19175839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, &amp; Sendtner M (2003). Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol, 163(4), 801–812. doi:10.1083/jcb.200304128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200304128</ArticleId>
            <ArticleId IdType="pmc">PMC2173668</ArticleId>
            <ArticleId IdType="pubmed">14623865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenten D, &amp; Medzhitov R (2011). The control of adaptive immune responses by the innate immune system. Adv Immunol, 109, 87–124. doi:10.1016/B978-0-12-387664-5.00003-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-12-387664-5.00003-0</ArticleId>
            <ArticleId IdType="pubmed">21569913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, &amp; Van Kooyk Y (2017). Neuroinflammation: Microglia and T Cells Get Ready to Tango. Front Immunol, 8, 1905. doi:10.3389/fimmu.2017.01905</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01905</ArticleId>
            <ArticleId IdType="pmc">PMC5788906</ArticleId>
            <ArticleId IdType="pubmed">29422891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shafey D, Cote PD, &amp; Kothary R (2005). Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res, 311(1), 49–61. doi:10.1016/j.yexcr.2005.08.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2005.08.019</ArticleId>
            <ArticleId IdType="pubmed">16219305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon CM, Dai Y, Van Alstyne M, Koutsioumpa C, Pagiazitis JG, Chalif JI, … Mentis GZ (2017). Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy. Cell Rep, 21(13), 3767–3780. doi:10.1016/j.celrep.2017.12.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.12.003</ArticleId>
            <ArticleId IdType="pmc">PMC5747328</ArticleId>
            <ArticleId IdType="pubmed">29281826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D, … Corti S (2016). Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?
Cell Mol Life Sci, 73(5), 1003–1020. doi:10.1007/s00018-015-2106-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-015-2106-9</ArticleId>
            <ArticleId IdType="pmc">PMC4756905</ArticleId>
            <ArticleId IdType="pubmed">26681261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sison SL, Patitucci TN, Seminary ER, Villalon E, Lorson CL, &amp; Ebert AD (2017). Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Hum Mol Genet, 26(17), 3409–3420. doi:10.1093/hmg/ddx230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx230</ArticleId>
            <ArticleId IdType="pubmed">28637335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun J, &amp; Harrington MA (2019). The Alteration of Intrinsic Excitability and Synaptic Transmission in Lumbar Spinal Motor Neurons and Interneurons of Severe Spinal Muscular Atrophy Mice. Front Cell Neurosci, 13, 15. doi:10.3389/fncel.2019.00015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2019.00015</ArticleId>
            <ArticleId IdType="pmc">PMC6374350</ArticleId>
            <ArticleId IdType="pubmed">30792629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, &amp; Bromberg MB (2005). Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol, 57(5), 704–712. doi:10.1002/ana.20473</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.20473</ArticleId>
            <ArticleId IdType="pmc">PMC4334582</ArticleId>
            <ArticleId IdType="pubmed">15852397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarabal O, Caraballo-Miralles V, Cardona-Rossinyol A, Correa FJ, Olmos G, Llado J, … Caldero J (2014). Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy. J Neuropathol Exp Neurol, 73(6), 519–535. doi:10.1097/NEN.0000000000000074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/NEN.0000000000000074</ArticleId>
            <ArticleId IdType="pubmed">24806302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor AS, Glascock JJ, Rose FF Jr., Lutz C, &amp; Lorson CL (2013). Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy. Transgenic Res, 22(5), 1029–1036. doi:10.1007/s11248-013-9702-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11248-013-9702-y</ArticleId>
            <ArticleId IdType="pmc">PMC3745810</ArticleId>
            <ArticleId IdType="pubmed">23512182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomson SR, Nahon JE, Mutsaers CA, Thomson D, Hamilton G, Parson SH, &amp; Gillingwater TH (2012). Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One, 7(12), e52605. doi:10.1371/journal.pone.0052605</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0052605</ArticleId>
            <ArticleId IdType="pmc">PMC3527597</ArticleId>
            <ArticleId IdType="pubmed">23285108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venereau E, Ceriotti C, &amp; Bianchi ME (2015). DAMPs from Cell Death to New Life. Front Immunol, 6, 422. doi:10.3389/fimmu.2015.00422</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2015.00422</ArticleId>
            <ArticleId IdType="pmc">PMC4539554</ArticleId>
            <ArticleId IdType="pubmed">26347745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vukojicic A, Delestree N, Fletcher EV, Pagiazitis JG, Sankaranarayanan S, Yednock TA, … G. Z. Mentis (2019). The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA. Cell Rep, 29(10), 3087–3100 e3087. doi:10.1016/j.celrep.2019.11.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.11.013</ArticleId>
            <ArticleId IdType="pmc">PMC6937140</ArticleId>
            <ArticleId IdType="pubmed">31801075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan B, Feng P, Guan Z, Sheng L, Liu Z, &amp; Hua Y (2018). A severe mouse model of spinal muscular atrophy develops early systemic inflammation. Hum Mol Genet, 27(23), 4061–4076. doi:10.1093/hmg/ddy300</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddy300</ArticleId>
            <ArticleId IdType="pubmed">30137324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao H, Coppola K, Schweig JE, Crawford F, Mullan M, &amp; Paris D (2019). Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFkappaB Antagonistic Activities. Front Cell Neurosci, 13, 457. doi:10.3389/fncel.2019.00457</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2019.00457</ArticleId>
            <ArticleId IdType="pmc">PMC6795686</ArticleId>
            <ArticleId IdType="pubmed">31649511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yong J, Wan L, &amp; Dreyfuss G (2004). Why do cells need an assembly machine for RNA-protein complexes?
Trends Cell Biol, 14(5), 226–232. doi:10.1016/j.tcb.2004.03.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2004.03.010</ArticleId>
            <ArticleId IdType="pubmed">15130578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zabel MK, &amp; Kirsch WM (2013). From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev, 12(3), 749–756. doi:10.1016/j.arr.2013.02.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arr.2013.02.001</ArticleId>
            <ArticleId IdType="pmc">PMC3700678</ArticleId>
            <ArticleId IdType="pubmed">23419464</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
